Amivantamab for previously untreated, locally advanced or metastatic EGFR exon 20 insertion mutation-positive non-small-cell lung cancer
Agency for Care Effectiveness (ACE)
Record ID 32018015214
English
Details
Project Status:
Completed
Year Published:
2026
URL for published report:
https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/amivantamab-for-previously-untreated--locally-advanced-or-metastatic-egfr-exon-20-insertion-mutation-positive-non-small-cell-lung-cancer/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Singapore
MeSH Terms
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Antibodies, Bispecific
- Antineoplastic Agents, Immunological
Contact
Organisation Name:
Agency for Care Effectiveness (ACE)
Contact Address:
Ministry of Health, College of Medicine Building, 16 College Road, Singapore 169854
Contact Name:
ACE_HTA@moh.gov.sg
Contact Email:
ACE_HTA@moh.gov.sg
Copyright:
Agency for Care Effectiveness (ACE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.